Human Female Genital Tract Infection by the Obligate Intracellular Bacterium Chlamydia trachomatis Elicits Robust Type 2 Immunity

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Vicetti Miguel, Rodolfo D ^a   Harvey, Stephen A K ^a   LaFramboise, William A ^a   Reighard, Seth D ^a   Matthews, Dean B ^a   Cherpes, Thomas L ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD200 RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 4; STROMELYSIN 2; TRANSCRIPTION FACTOR GATA 3; TUMOR NECROSIS FACTOR;

ADOLESCENT; ADULT; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL ISOLATION; CELLULAR IMMUNITY; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONTROLLED STUDY; FEMALE; FEMALE GENITAL TRACT INFECTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; INFECTION CONTROL; INTRACELLULAR BACTERIUM; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE PROLIFERATION; MACROPHAGE ACTIVATION; MICROARRAY ANALYSIS; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; POLARIZATION; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; ANTIGENS, CD; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; MACROPHAGE ACTIVATION; TH2 CELLS;

EID: 84874841291     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0058565     Document Type: Article

References (37)

1. Hu VH, Harding-Esch EM, Burton MJ, Bailey RL, Kadimpeul J, et al. (2011) Epidemiology and control of trachoma: systematic review. Trop Med Int Health 15: 673-691.
2. Geisler WM, (2010) Duration of untreated, uncomplicated Chlamydia trachomatis genital infection and factors associated with Chlamydia resolution: a review of human studies. J Infect Dis 201: S104-S113.
3. Peipert JF, (2003) Clinical practice. Genital chlamydial infections. N Engl J Med 349: 2424-2430.
4. Molano M, Meijer CJLM, Weiderpass E, Arslan A, Posso H, et al. (2005) The natural course of Chlamydia trachomatis infection in asymptomatic Colombian women: a 5-year follow-up study. J Infect Dis 191: 907-916.
5. Brunham RC, Rey-Ladino J, (2005) Immunology of Chlamydia infection: implications for a Chlamydia trachomatis vaccine. Nat Rev Immunol 5: 149-161.
6. Vicetti Miguel RD, Cherpes TL, (2012) Hypothesis: Chlamydia trachomatis infection of the female genital tract is controlled by Type 2 immunity. Med Hypotheses 79: 713-716.
7. Darville T, Hiltke TJ, (2010) Pathogenesis of genital tract disease due to Chlamydia trachomatis. J Infect Dis 201: S114-125.
8. Allen JE, Maizels RM, (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11: 375-388.
9. Anthony RM, Urban JF Jr, Alem F, Hamed HA, Rozo CT, et al. (2006) Memory TH2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nature Med 12: 955-960.
10. Vicetti Miguel RD, Reighard SD, Chavez JM, Rabe LK, Maryak SA, et al. (2012) Transient detection of chlamydial-specific Th1 memory cells in the peripheral circulation of women with history of Chlamydia trachomatis genital tract infection. Amer J Repro Immunol 68: 499-506.
11. Graham AL, Allen JE, Read AF, (2005) Evolutionary causes and consequences of immunopathology. Annu Rev Ecol Evol Syst 36: 373-397.
12. Conca W, Willmroth F, (1994) Human T lymphocytes express a member of the matrix metalloproteinase gene family. Arthritis Rheum 37: 951-956.
13. Van Themsche C, Alain T, Kossakowska AE, Urbanski S, Potworowski EF, et al. (2004) Stromelysin-2 (matrix metalloproteinase 10) is inducible in lymphoma cells and accelerates the growth of lymphoid tumors in vivo. J Immunol 173: 3605-3611.
14. Fichtner-Feigl S, Strober W, Kawakami K, Puri RK, Kitani A, (2006) IL-13 signaling through the IL-13α2 receptor is involved in induction of TGF-β1 production and fibrosis. Nat Med 12: 99-106.
15. Fichtner-Feigl S, Young CA, Kitani A, Geissler EK, Schlitt HJ, et al. (2008) IL-13 signaling via IL-13Rα2 induces major downstream fibrogenic factors mediating fibrosis in chronic TNBS colitis. Gastroenterology 135: 2003-2013.
16. Wang M, Liang P, (2005) Interleukin-24 and its receptors. Immunol 114: 166-170.
17. Schaefer G, Venkataraman C, Schindler U, (2001) Cutting edge: FISP (IL-4 induced secreted protein), a novel cytokine-like molecule secreted by Th2 cells. J Immunol 166: 5859-5863.
18. Soo C, Shaw WW, Freymiller E, Longaker MT, Bertolami CN, et al. (1999) Cutaneous rat wounds express c49a, a novel gene with homology to the human melanoma differentiation associated gene, mda-7. J Cell Biochem 74: 1-10.
19. Hebbar V, Damera G, Sachdev GP, (2005) Differential expression of MUC genes in endometrial and cervical tissues and tumors. BMC Cancer 27: 124.
20. Turner J, Jones CE, (2009) Regulation of mucin expression in respiratory diseases Biochem Soc Trans. 37: 877-881.
21. Jardim MJ, Dailey L, Silbajoris R, Diaz-Sanchez D, (2012) Distinct microRNA expression in human airway cells of asthmatic donors identifies a novel asthma-associated gene. Am J Respir Cell Mol Biol 47: 536-542.
22. Wilson BJ, Giguère V, (2008) Meta-analysis of human cancer microarray reveals GATA3 is integral to the estrogen receptor alpha pathway. Mol Cancer 7: 49.
23. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
24. Allen JE, Wynn TA, (2011) Evolution of Th2 immunity: a rapid repair response to the tissue destructive pathogens. PLoS Pathogens 11: 375-388.
25. Pulendran B, Artis D, (2012) New paradigms in type 2 immunity. Science 337: 431-435.
26. Martinez FO, Helming L, Gordon S, (2009) Alternative activation of macrophages: an immunologic functional perspective. Annu Rev Immunol 27: 451-483.
27. Hoek RM, Ruuls SR, Murphy CA, Wright GJ, Goddard R, et al. (2000) Downregulation of the macrophage lineage through interaction with OX2 (CD200). Science 290: 1768-1771.
28. Barclay AN, Wright GJ, Brooke G, Brown MH, (2002) CD200 and membrane protein interactions in the control of myeloid cells. Trends Immunol 23: 285-290.
29. Snelgrove RJ, Goulding J, Didierlaurent AM, Lyonga D, Vekaria S, et al. (2008) A critical function for CD200 in lung immune homeostasis and the severity of influenza infection. Nat Immunol 9: 1074-1083.
30. Stein M, Keshav S, Harris N, Gordon S, (1992) Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med 176: 287-292.
31. Vicetti Miguel RD, Hendricks RL, Aguirre AJ, Melan MA, Harvey SAK, et al. (2012) Dendritic cell activation and memory cell development are impaired among mice administered medroxyprogesterone acetate prior to mucosal herpes simplex virus type 1 Infection. J Immunol 189: 3449-3461.
32. Busslinger M, (2004) Transcriptional control of early B cell development. Annu Rev Immunol 22: 55-79.
33. Cobaleda C, Schebesta A, Delogu A, Busslinger M, (2007) Pax5: the guardian of B cell identify and function. Nat Immunol 5: 463-470.
34. Taylor BD, Darville T, Ferrell RE, Ness RB, Haggerty CL (2013) Racial variation in Toll-like Receptor variants among women with pelvic inflammatory disease. J Infect Dis (in press).
35. Cohen CR, Koochesfahani KM, Meier AS, Shen C, Karunakaruna K, et al. (2005) Immunoepidemiologic profile of Chlamydia trachomatis infection: importance of heat-shock protein 60 and interferon-γ. J Infect Dis 192: 591-599.
36. Vicetti Miguel RD, Maryak SA, Cherpes TL, (2012) Brefeldin A, but not monensin, enables flow cytometric detection of interleukin-4 within peripheral T cells responding to ex vivo stimulation with Chlamydia trachomatis. J Immunol Methods 384: 191-195.
37. Tanaka G, Kanaji S, Hirano A, Arima K, Shinagawa A, et al. (2005) Induction and activation of the aryl hydrocarbon receptor by IL-4 in B cells. Int Immunol 17: 797-805.